Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
13.26
+0.10 (0.76%)
Feb 4, 2026, 3:04 PM CST

SHE:300406 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Operating Revenue
1,4221,6481,7371,5081,598847.24
Other Revenue
11.2811.284.42.8810.88
1,4331,6591,7421,5111,599848.12
Revenue Growth (YoY)
-17.88%-4.75%15.27%-5.53%88.58%0.86%
Cost of Revenue
291.05361.88445.01384.12448.5328.44
Gross Profit
1,1421,2971,2971,1271,151519.67
Selling, General & Admin
428.95457.67491.04457.36444.38244.92
Research & Development
186.81188.53162.9137.2127.0179.06
Other Operating Expenses
24.9515.4514.9712.8512.922.88
Operating Expenses
649.11665.03692.35625.46602.71353.83
Operating Income
493.09632.01604.27501.29548.17165.84
Interest Expense
-48.36-47.61-46.99-52.64-21.59-8.16
Interest & Investment Income
19.5719.8225.9521.4815.746.61
Currency Exchange Gain (Loss)
-0.1-0.1-0.122.21-0.290.84
Other Non Operating Income (Expenses)
3.92.39-3.5-28.33-19.94-25.09
EBT Excluding Unusual Items
468.1606.52579.62444.01522.09140.04
Impairment of Goodwill
----3.03--
Gain (Loss) on Sale of Investments
-1.04----0.06
Gain (Loss) on Sale of Assets
-1.81-2.11-3.5-2.680.16-1.03
Asset Writedown
-1.38-1.38-0.21-2.29-0.11-0.18
Other Unusual Items
22.2517.6617.6413.3514.85-1.96
Pretax Income
486.12620.69593.55449.35536.99136.93
Income Tax Expense
54.2989.5371.4854.8967.3315.25
Earnings From Continuing Operations
431.83531.16522.07394.46469.66121.68
Minority Interest in Earnings
-0.121.471.67-5.37-64.01-9.4
Net Income
431.71532.64523.74389.1405.65112.28
Net Income to Common
431.71532.64523.74389.1405.65112.28
Net Income Growth
-17.90%1.70%34.60%-4.08%261.30%-66.15%
Shares Outstanding (Basic)
579579582581588548
Shares Outstanding (Diluted)
592592595614588548
Shares Change (YoY)
-1.02%-0.56%-3.00%4.37%7.25%9.09%
EPS (Basic)
0.750.920.900.670.690.20
EPS (Diluted)
0.730.900.880.670.690.20
EPS Growth
-17.05%2.27%31.47%-2.99%236.88%-68.97%
Free Cash Flow
598.81546.36437.06299.69275.9105.81
Free Cash Flow Per Share
1.010.920.730.490.470.19
Dividend Per Share
0.9000.4000.2000.1000.1000.099
Dividend Growth
350.00%100.00%100.00%-0.66%-33.77%
Gross Margin
79.69%78.19%74.45%74.58%71.96%61.27%
Operating Margin
34.40%38.10%34.70%33.18%34.27%19.55%
Profit Margin
30.12%32.11%30.07%25.75%25.36%13.24%
Free Cash Flow Margin
41.78%32.93%25.09%19.84%17.25%12.48%
EBITDA
572.94700.68658.03554.35590.51196.05
EBITDA Margin
39.98%42.24%37.78%36.69%36.92%23.12%
D&A For EBITDA
79.8568.6753.7653.0542.3330.21
EBIT
493.09632.01604.27501.29548.17165.84
EBIT Margin
34.40%38.10%34.70%33.18%34.27%19.55%
Effective Tax Rate
11.17%14.42%12.04%12.22%12.54%11.14%
Revenue as Reported
1,4331,6591,742-1,599-
Advertising Expenses
-153.01194.01200.07186.98106.68
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.